Am J Epidemiol

1. BRAITMAIER M, Schwarz S, Didelez V, Haug U, et al
   Misleading and avoidable: design-induced biases in observational studies evaluating cancer screening-the example of site-specific effectiveness of screening colonoscopy.
   Am J Epidemiol. 2026;195:300-306.
   

   >> Share

   
   

   
   Am J Surg

2. CHOI YH, Huh JW, Lee WY, Yun SH, et al
   Risk factors for lymph node metastasis in p/ypT1-2 rectal cancer.
   Am J Surg. 2026;253:116782.
   

   >> Share

   
   

   
   Ann Surg Oncol

3. MOROCHO B, Lightfoot S, Somasundar P, Kwon S, et al
   Trends and Outcomes of the Liver-First Surgical Approach for Patients with Colorectal Cancer and Isolated Liver Metastases.
   Ann Surg Oncol. 2026 Feb 3. doi: 10.1245/s10434-026-19180.
   

   >> Share

   
   
4. GUPTA P, Godfrey EL, Schultz KS, Qiao L, et al
   Consensus Molecular Subtypes Inform HIPEC Agent Selection in Colorectal Cancer Peritoneal Metastases.
   Ann Surg Oncol. 2026 Feb 3. doi: 10.1245/s10434-025-19057.
   

   >> Share

   
   

   
   Anticancer Res

5. KUO CY, Liao TL, Hsu FT, Chang CM, et al
   Lenvatinib Exhibits Potent Anti-tumor Activity and Favorable Safety Profile in a Colorectal Cancer Xenograft Model.
   Anticancer Res. 2026;46:797-810.
   

   >> Share

   
   
6. KIM HB, Lee HJ, Park SG
   Oncogenic Role and Clinical Significance of NPM1 in Colorectal Cancer via the AKT/mTOR Signaling Pathway.
   Anticancer Res. 2026;46:727-736.
   

   >> Share

   
   
7. SEKI Y, Shibutani M, Tanda H, Tsukida T, et al
   Impact of the Immunonutritional Status on the Feasibility of Subsequent Treatment After the Discontinuation of Trifluridine-Tipiracil Plus Bevacizumab Therapy in Patients With Metastatic Colorectal Cancer.
   Anticancer Res. 2026;46:1117-1122.
   

   >> Share

   
   
8. INOUE A, Ota H, Matsuura Y, Munakata K, et al
   First-line FOLFOXIRI-based Chemotherapy for Unresectable Metastatic Colorectal Cancer: Real-world Outcomes, Safety, and Conversion Surgery.
   Anticancer Res. 2026;46:975-985.
   

   >> Share

   
   
9. KUWATA D, Shimoda H, Miura T, Chiba T, et al
   Anatomical-specific Lymphatic Route Beyond Mesorectal Fascia: Analyses from Female Cadavers and Patients With Rectal Cancer.
   Anticancer Res. 2026;46:885-899.
   

   >> Share

   
   
10. KIM J, Han Q, Li S, Kang BM, et al
    Lack of Cancer Specificity of Methionine Adenosyltransferase 2A (MAT2A) Inhibitor AG-270 in Combination With Recombinant Methioninase In Vitro.
    Anticancer Res. 2026;46:705-712.
    

    >> Share

    
    
11. TANDA H, Shibutani M, Seki Y, Nishiyama T, et al
    The Usefulness of the Modified Controlling Nutritional Status Score for Assessing Prognosis in Patients With Colorectal Cancer.
    Anticancer Res. 2026;46:1097-1105.
    

    >> Share

    
    
12. YAMANAKA R, Matsumoto N, Murase R, Kubota Y, et al
    Polymorphisms of FGFR Pathway-related Factors and Capecitabine-induced Hand-foot Syndrome in Japanese Patients With Colorectal Cancer.
    Anticancer Res. 2026;46:835-846.
    

    >> Share

    
    
13. OKADO S, Nakamura S, Sugihara M, Kinoshita F, et al
    Prognostic Factors for Pulmonary Metastasectomy for Colorectal Cancer: A Propensity Score Matching Analysis.
    Anticancer Res. 2026;46:1143-1152.
    

    >> Share

    
    

    
    BMC Cancer

14. TRAN CG, Dornbush C, Jensen BS, Mott SL, et al
    Obesity, survival, and chemotherapy outcomes in stage IV colorectal cancer: a retrospective study.
    BMC Cancer. 2026 Feb 5. doi: 10.1186/s12885-026-15653.
    

    >> Share

    
    
15. XIE H, Chen T, Lan B, Zhou Q, et al
    The prognostic value of preoperative Naples prognostic score for overall survival and progression-free survival in colorectal cancer.
    BMC Cancer. 2026 Feb 3. doi: 10.1186/s12885-026-15679.
    

    >> Share

    
    
16. ERDOGAN ASO, Shu Y, Gootjes E, Simmer F, et al
    Patients with tumor deposits benefit equally from adjuvant therapy compared to other stage III colon cancer groups: two retrospective population-based studies.
    BMC Cancer. 2026 Feb 6. doi: 10.1186/s12885-026-15668.
    

    >> Share

    
    

    
    BMC Gastroenterol

17. GE L, Liu S, Yu S, Li M, et al
    Artemether as a modulator of EMT in colorectal cancer: enhancing radiosensitivity and reversing chemo-radiation resistance.
    BMC Gastroenterol. 2026 Feb 4. doi: 10.1186/s12876-026-04653.
    

    >> Share

    
    
18. FUJII T, Hirasaki M, Kamakura Y, Kawasaki T, et al
    Correction: Evaluation of PINK1 protein expression as a predictive marker for the efficacy of adjuvant chemotherapy in colorectal cancer: a retrospective study.
    BMC Gastroenterol. 2026;26:99.
    

    >> Share

    
    

    
    Br J Cancer

19. AIJALA VK, Harkonen J, Sirnio P, Mantere T, et al
    Urothelium marker UPK2 identifies aggressive colorectal cancers with distinct molecular and histological features.
    Br J Cancer. 2026;134:650-661.
    

    >> Share

    
    
20. SOLE L, Canton E, Maqueda M, Lobo-Jarne T, et al
    ColoStem, a core oncofetal signature that identifies poor prognosis colorectal tumors.
    Br J Cancer. 2026;134:638-649.
    

    >> Share

    
    

    
    Cancer Res

21. ZANI F, Blagih J
    Drink Responsibly: Cancer Cells Also Like Sugary Drinks.
    Cancer Res. 2026;86:569-570.
    

    >> Share

    
    

    
    Clin Med Insights Oncol

22. OYELAMI M, Mgbeke O, Obadiah AA, Egbeyemi A, et al
    The Prognostic Significance of KRAS, NRAS, and BRAF Mutations in Colorectal Cancer: A Systematic Review and Meta-Analysis.
    Clin Med Insights Oncol. 2026;20:11795549261417367.
    

    >> Share

    
    

    
    Eur J Cancer

23. FRANKEN IA, Ketelaars SLC, Rubio-Alarcon C, Delis-van Diemen P, et al
    Cancer-associated fibroblast signature and SMAD4 mutation in resistance to adjuvant chemotherapy in stage III colon cancer patients.
    Eur J Cancer. 2026;236:116262.
    

    >> Share

    
    

    
    Eur J Gastroenterol Hepatol

24. WU KW, Liang KS, Hsu YC, Lee FJ, et al
    Association between metabolic dysfunction-associated steatotic liver disease, lean metabolic dysfunction-associated steatotic liver disease, and colorectal neoplasms: a cross-sectional study.
    Eur J Gastroenterol Hepatol. 2026;38:216-221.
    

    >> Share

    
    

    
    Eur J Surg Oncol

25. JISHU JA, Bruce D, Abu AlSel BT, Othman R, et al
    Minimally invasive approaches for early-stage rectal cancer: A comparative analysis from the TriNetX network.
    Eur J Surg Oncol. 2026;52:111318.
    

    >> Share

    
    
26. UNE N, Kobayashi S, Kudo M, Sugimoto M, et al
    Response to chemotherapy as a key factor in time to surgical failure following conversion hepatectomy for initially unresectable colorectal liver metastases: A retrospective cohort study.
    Eur J Surg Oncol. 2026;52:111317.
    

    >> Share

    
    
27. HASIL L, Milks A, Panagakos A, Engel D, et al
    What is the impact of nutrition interventions on incidence of anastomotic leak after colorectal surgery? A systematic review of randomized trials.
    Eur J Surg Oncol. 2026;52:111321.
    

    >> Share

    
    
28. GRANADOS-MATURANO A, Garcia-Nalda A, Pallisera-Lloveras A, Pujol-Caballe G, et al
    Colorectal cancer surgery in elderly and frail patients: Should we leave someone behind?
    Eur J Surg Oncol. 2026;52:111406.
    

    >> Share

    
    

    
    Gastroenterology

29. ICHIMASA K, Kudo SE, Misawa M
    Beyond Curability: Age and Surgical Risk in Individualized Treatment of T1 Colorectal Cancer.
    Gastroenterology. 2026 Feb 3:S0016-5085(26)00093.
    

    >> Share

    
    
30. AGARGUN BF, Besisik F
    Caution in Generalizing the Safety of Isolated Deep Submucosal Invasion in T1 Colorectal Cancer.
    Gastroenterology. 2026 Feb 3:S0016-5085(26)00095.
    

    >> Share

    
    
31. NAKAJIMA K, Saito H, Nishikawa Y
    Shared Decision Making in the Management of High-Risk T1 Colorectal Cancer.
    Gastroenterology. 2026 Feb 3:S0016-5085(26)00094.
    

    >> Share

    
    

    
    Gut

32. LADABAUM U, Font Marimon R, Castells Olivera X, Balaguer F, et al
    Effect of long-term adherence on faecal immunochemical test positivity rate, positive predictive value and detection rate in organised population-based colorectal cancer screening.
    Gut. 2026 Jan 30:gutjnl-2025-336994. doi: 10.1136/gutjnl-2025-336994.
    

    >> Share

    
    

    
    Int J Colorectal Dis

33. JIAO Y, Xie H, Zhou X, Kong X, et al
    A novel caudal-dorsal approach for laparoscopic right hemicolectomy with complete mesocolic excision.
    Int J Colorectal Dis. 2026;41:55.
    

    >> Share

    
    
34. HAN SJ, Lee HS, Jang BI, Kim JH, et al
    Impact of gross tumor morphology on the clinical outcomes of colon cancer: multicenter retrospective cohort study.
    Int J Colorectal Dis. 2026;41:57.
    

    >> Share

    
    
35. CHEN X, Zheng Z, Liu K
    Integrative bioinformatics and machine learning approaches identify novel diagnostic signatures for oxaliplatin-resistant colorectal cancer.
    Int J Colorectal Dis. 2026;41:60.
    

    >> Share

    
    
36. PAN Z, Peng T, Wang Y, Chen B, et al
    Interpretable AI-driven prediction of early postoperative recurrence in locally advanced rectal cancer using the Systemic Inflammatory-Nutritional Index (SINTI): A multi-center study and clinical web tool.
    Int J Colorectal Dis. 2026;41:58.
    

    >> Share

    
    
37. MATTEUCCI M, Barone G, Zampino L, Codeca C, et al
    Colonic metastasis from breast carcinoma: A case report and systematic review of a rare clinical scenario.
    Int J Colorectal Dis. 2026;41:61.
    

    >> Share

    
    

    
    J Surg Oncol

38. SUN Y, Weng Y, Zhang Q, Sun Y, et al
    Effects of Closed Continuous Irrigation and Drainage Technique Combined With Narrative Nursing in Ultra-Low Rectal Cancer Patients Who Received Anus-Preserving Operation.
    J Surg Oncol. 2026;133:143-152.
    

    >> Share

    
    

    
    Lancet Oncol

39. MARINGE C, O'Leary D, Benitez-Majano S, Leyrat C, et al
    Estimated effect of correcting inequalities in minimally invasive surgical resection in patients with colon cancer in England: a population-based study.
    Lancet Oncol. 2026;27:212-222.
    

    >> Share

    
    

    
    Minerva Gastroenterol (Torino)

40. VASURI F, Boccaccino A, Zingaretti C, Banchelli I, et al
    Clinicopathological features of mismatch repair-deficient colorectal cancer: an observational experience from Romagna, Italy.
    Minerva Gastroenterol (Torino). 2026 Jan 30. doi: 10.23736/S2724-5985.25.04090.
    

    >> Share

    
    

    
    Oncol Rep

41. GUO Z, Zhuang H, Liu Q
    Origin dictates function: The dual roles of exosomes derived from diverse origins in the onset and progression of colorectal cancer (Review).
    Oncol Rep. 2026;55:64.
    

    >> Share

    
    

    
    Oncology

42. MIYAKITA H, Ogimi T, Kayano H, Mori M, et al
    Changes in Tumor-Infiltrating Lymphocytes and Inflammatory Blood Factors during Chemoradiation Therapy in Rectal Cancer.
    Oncology. 2026;104:137-144.
    

    >> Share

    
    

    
    PLoS One

43. ZHANG XF, Zhang XL, Xu HW, Lin YH, et al
    ITIH2 in colorectal cancer metastasis: Weighted Gene Co-expression Network Analysis-guided functional validation.
    PLoS One. 2026;21:e0329719.
    

    >> Share

    
    
44. ZUBAIR NF, Mohammed Nawi A, Hassan MR, Daud A, et al
    Multilevel factors influencing colorectal cancer screening adherence: A systematic literature review.
    PLoS One. 2026;21:e0342184.
    

    >> Share

    
    
45. SONG S, Zhang Y, Li L, Zhou K, et al
    Nucleolar protein 6 as a potential oncogenic factor in colorectal cancer.
    PLoS One. 2026;21:e0340047.
    

    >> Share

    
    
46. 
    Correction: Diagnostic performance of eNose technology in detecting colorectal cancer recurrence: A prospective evaluation.
    PLoS One. 2026;21:e0342238.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share